Delivery Order SPE2DE24D0013-SPE2D625F60FH

Award Date 2/4/25
Potential Completion Date 2/11/25
Potential Value $10K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $30,912.00 firm fixed-price delivery order contract is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These products enable rapid detection and diagnosis of infectious diseases such as COVID-19, influenza, and respiratory syncytial...
This federal contract award, with ID SPE2DE24D0013|SPE2D625F59MW, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $19,048.25 firm fixed-price delivery order contract is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other...
This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
The federal contract award SPE2DE24D0013|SPE2D625F33ER was issued by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $7,834.28 firm fixed-price delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other clinical conditions....
This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The $10,200 firm fixed-price delivery order contract is to support the detection and diagnosis of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical conditions for various...
This is a federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,085.37 and is a firm fixed-price delivery order with no set-aside designation. The contract is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has an award value of $5,440.00 and is a firm fixed-price delivery order. Cepheid will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, and test kits, to support the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency, an agency that supports the U.S. Department of Defense. The contract, valued at $27,200.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV)....
This federal contract award, valued at $1,297.20, was issued by the Defense Logistics Agency's Medical Supply Chain division to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The award is a firm fixed-price delivery order contract with no set-aside designation. Cepheid will provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, respiratory...
This federal contract award to Cepheid, a manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency, a component of the U.S. Department of Defense. The $10,914.00 delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract is a firm fixed-price award...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F60FH
    Delivery Order

This federal contract award, valued at $10,200.00, was issued by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is a delivery order with a firm fixed-price pricing type, and does not have any set-aside designation.

The award is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of various infectious diseases, including COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The contract has an ultimate completion date of February 11, 2025.

In addition to this specific contract award, Cepheid holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the Indian Health Service and the Department of Veterans Affairs (VA), enabling these agencies to continuously procure Cepheid's molecular diagnostic solutions. Cepheid has also participated as a subrecipient on specialized research projects, collaborating with academic institutions and other organizations on advancing diagnostic capabilities.

Generated 5/6/25, 9:54 AM